Skip to main content

Table 4 Observed vs. Predicted EQ-5D Utility by symptom group from QLQ-C30 + MY20 model

From: Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma

 

Actual

Predicted (95% CI)

Difference

Symptom group

   

  Asymptomatic

0.923

0.893 (0.819; 0.967)

0.030

  Mildly symptomatic

0.806

0.833 (0.783; 0.883)

−0.027

  Moderately symptomatic

0.675

0.679 (0.616; 0.743)

−0.004

  Severely symptomatic

0.501

0.474 (0.398; 0.551)

0.027